Get started
RocketTickers

Eiger Announces FDA Breakthrough Therapy Designation for Avexiti

Long
RocketTickers  
NASDAQ:EIGR   None
Beyond Technical Analysis
0
0
beyondta
EIGR: Eiger BioPharmaceuticals, Inc.
2021-08-05 08:00:00
Eiger Announces FDA Breakthrough Therapy Designation for Avexitide for Treatment of Congenital Hyperinsulinism
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.